Antiviral Drug Strategies (Methods and Principles in Medicinal Chemistry) - novo libro

EAN (ISBN-13): 9783527326969
ISBN (ISBN-10): 3527326960
Livro de capa dura
Ano de publicação: 2011
Editor/Editora: Wiley-VCH
406 Páginas
Peso: 0,946 kg
Língua: eng/Englisch

Livro na base de dados desde 2008-06-20T08:28:49+01:00 (Lisbon)
Página de detalhes modificada pela última vez em 2023-01-27T21:40:15+00:00 (Lisbon)
Número ISBN/EAN: 3527326960

Número ISBN - Ortografia alternativa:
3-527-32696-0, 978-3-527-32696-9
Ortografia alternativa e termos de pesquisa relacionados:
Autor do livro: clercq, kubinyi, clerc, hugo, wiley vch, gerd folkers
Título do livro: principles chemistry

---

Dados da editora

Autor: Erik De Clercq
Título: Methods and Principles in Medicinal Chemistry; Antiviral Drug Strategies
Editora: Wiley-VCH; Wiley-VCH
406 Páginas
Ano de publicação: 2011-04-06
Impresso / Feito em
Peso: 0,970 kg
Língua: Inglês
195,00 € (DE)
Not available (reason unspecified)
170mm x 240mm x 26mm

BB; Hardcover, Softcover / Chemie; Medizinische Chemie, Pharmazeutische Chemie; Verstehen; Chemie; Biowissenschaften; Chemie; Chemistry; Drug Discovery & Development; Life Sciences; Virologie; Virology; Wirkstoffforschung; Wirkstoffforschung u. -entwicklung; Wirkstoffforschung u. -entwicklung; Virologie

New viruses can arise very quickly and, if unchecked, result in major pandemics. Obvious examples being the AIDS and SARS virus. In order to deal with such imminent threats, drug development times need to be cut short. This is only possible by relying on proven strategies and adapting them to the specific features of any new virus or virus variant. By focusing on general molecular mechanisms of antiviral drugs rather than therapies for individual viruses, this ready reference provides the critical knowledge needed to develop entirely novel therapeutics and to target new viruses. It is edited by Erik de Clercq, a world authority on antiviral drug discovery. The volume covers a general discussion of antiviral strategies, followed by a broad survey of known viral targets, such as reverse transcriptases, proteases, neuraminidases, RNA polymerases, helicases, and primases, as well as their known inhibitors. The book also contains several case studies of recent successful antiviral drug development. As a result, medicinal and pharmaceutical chemists, as well as virologists will be able to pinpoint strategies for combating future viral pandemics.